Evidence map›Paper›PMID 32025001›Full record

ArticleNature genetics2020

The landscape of viral associations in human cancers.

Marc Zapatka, Ivan Borozan, Daniel S Brewer, Murat Iskar, Adam Grundhoff, Malik Alawi, Nikita Desai, Holger Sültmann, Holger Moch, PCAWG Pathogens and 5 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 250 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
250citing papers in PubMed, 2 pooled it
24.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

250 citing papers in PubMed, 2 syntheses or guidelines pooled it, 392 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Detection of AdenoviralInternational journal of molecular sciences · 2026
    Article
  20. Journal of virology · 2026
    Article

190 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 17 institutions in 6 countries.

Marc Zapatka *Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8287-5967
Ivan Borozan *Informatics and Bio-computing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-3145-3550
Daniel S Brewer *Norwich Medical School, University of East Anglia, Norwich, UK.ORCID http://orcid.org/0000-0003-4753-9794
Murat Iskar *Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Adam GrundhoffHeinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.ORCID http://orcid.org/0000-0003-0940-7045
Malik AlawiHeinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.ORCID http://orcid.org/0000-0002-5993-7709
Nikita DesaiBioinformatics Group, Department of Computer Science, University College London, London, UK.
Holger SültmannNational Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
Holger MochDepartment of Pathology and Molecular Pathology, University and University Hospital Zürich, Zurich, Switzerland.
PCAWG Pathogens
Colin S CooperNorwich Medical School, University of East Anglia, Norwich, UK.
Roland EilsDivision of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-0034-4036
Vincent FerrettiOntario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada.
Peter LichterDivision of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany. peter.lichter@dkfz-heidelberg.de.ORCID http://orcid.org/0000-0002-2960-5279
PCAWG Consortium
German Cancer Research Center · DEInstitute of Cancer Research · GBDana-Farber Cancer Institute · USLeibniz Institute of Virology (LIV) · DEOntario Institute for Cancer Research · CAThe University of Texas MD Anderson Cancer Center · USUniversity of East Anglia · GBEarlham Institute · GBUniversity of Alabama at Birmingham · USThe Francis Crick Institute · GBBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEHeidelberg University · DEUniversité de Montréal · CABroad Institute · USRIKEN Center for Integrative Medical Sciences · JPUniversität Hamburg · DEUniversity Hospital of Zurich · CH

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Cancer Research UK 23924NCI NIH HHS P30 CA016672NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, for which whole-genome and-for a subset-whole-transcriptome sequencing data from 2,658 cancers across 38 tumor types was aggregated, we systematically investigated potential viral pathogens using a consensus approach that integrated three independent pipelines. Viruses were detected in 382 genome and 68 transcriptome datasets. We found a high prevalence of known tumor-associated viruses such as Epstein-Barr virus (EBV), hepatitis B virus (HBV) and human papilloma virus (HPV; for example, HPV16 or HPV18). The study revealed significant exclusivity of HPV and driver mutations in head-and-neck cancer and the association of HPV with APOBEC mutational signatures, which suggests that impaired antiviral defense is a driving force in cervical, bladder and head-and-neck carcinoma. For HBV, HPV16, HPV18 and adeno-associated virus-2 (AAV2), viral integration was associated with local variations in genomic copy numbers. Integrations at the TERT promoter were associated with high telomerase expression evidently activating this tumor-driving process. High levels of endogenous retrovirus (ERV1) expression were linked to a worse survival outcome in patients with kidney cancer.

Indexed as

TranscriptomeVirus IntegrationDNA Copy Number VariationsDNA Tumor VirusesGenome, HumanHepatitis B virusHerpesvirus 4, HumanHumansMutationNeoplasmsPapillomavirus InfectionsPromoter Regions, GeneticTelomeraseTumor Virus InfectionsTelomeraseTERT protein, human

Identifiers

PMID32025001
PMCPMC8076016
OpenAlexW3005400930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.